Novel orphan nuclear receptors-coregulator interactions controlling anti-cancer drug metabolism.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Current drug metabolism

• Publication date

  2008-08-31

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.2174/138920008785821701PMID 18781912
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inhibition of drug metabolism by blocking the activation of nuclear receptors by ketoconazole

  2007cited by this paper
• The role of nuclear receptors in pharmacokinetic drug-drug interactions in oncology.

  2007cited by this paper
• Functional Inhibitory Cross-talk between Constitutive Androstane Receptor and Hepatic Nuclear Factor-4 in Hepatic Lipid/Glucose Metabolism Is Mediated by Competition for Binding to the DR1 Motif and to the Common Coactivators, GRIP-1 and PGC-1α*

  2006cited by this paper
• Intestinal and Hepatic CYP3A4 Catalyze Hydroxylation of 1α,25-Dihydroxyvitamin D3: Implications for Drug-Induced Osteomalacia

  2006cited by this paper
• RIFAMPICIN INDUCTION OF CYP3A4 REQUIRES PREGNANE X RECEPTOR CROSS TALK WITH HEPATOCYTE NUCLEAR FACTOR 4α AND COACTIVATORS, AND SUPPRESSION OF SMALL HETERODIMER PARTNER GENE EXPRESSION

  2006cited by this paper
• Synthetic Drugs and Natural Products as Modulators of Constitutive Androstane Receptor (Car) and Pregnane X Receptor (PXR)

  2006cited by this paper
• Differential Regulation of Hepatic CYP2B6 and CYP3A4 Genes by Constitutive Androstane Receptor but Not Pregnane X Receptor

  2006cited by this paper
• Activation of the Steroid and Xenobiotic Receptor (Human Pregnane X Receptor) by Nontaxane Microtubule-Stabilizing Agents

  2005cited by this paper
• Functional analysis of four naturally occurring variants of human constitutive androstane receptor.

  2005cited by this paper
• Steroid and xenobiotic receptor (SXR), cytochrome P450 3A4 and multidrug resistance gene 1 in human adult and fetal tissues.

  2005cited by this paper
• The nuclear xenobiotic receptor pregnane X receptor: recent insights and new challenges.

  2005cited by this paper
• Possible involvement of pregnane X receptor-enhanced CYP24 expression in drug-induced osteomalacia.

  2005cited by this paper
• The Nuclear Receptors Constitutive Androstane Receptor and Pregnane X Receptor Cross-Talk with Hepatic Nuclear Factor 4α to Synergistically Activate the Human CYP2C9 Promoter

  2005cited by this paper
• Peroxisome proliferator‐activated receptor‐γ co‐activator‐1α (PGC‐1α) gene polymorphisms and their relationship to Type 2 diabetes in Asian Indians

  2005cited by this paper
• Variation in estrogen-related genes and cross-sectional and longitudinal blood pressure in the Framingham Heart Study

  2005cited by this paper
• Structural insights into the interaction and activation of histone deacetylase 3 by nuclear receptor corepressors

  2005cited by this paper
• The CAR nuclear receptor and hepatocyte proliferation

  2005cited by this paper
• [Drug-induced osteomalacia : possible role of PXR, a receptor involved in detoxification].

  2005cited by this paper
• Ligand-activated Pregnane X Receptor Interferes with HNF-4 Signaling by Targeting a Common Coactivator PGC-1α

  2004cited by this paper
• The nuclear xenobiotic receptor CAR: structural determinants of constitutive activation and heterodimerization.

  2004cited by this paper
• The role of corepressors in transcriptional regulation by nuclear hormone receptors.

  2004cited by this paper
• Nuclear receptors and the control of metabolism.

  2003cited by this paper
• Contribution of variants in the small heterodimer partner gene to birthweight, adiposity, and insulin levels: mutational analysis and association studies in multiple populations.

  2003cited by this paper
• Induction of cytochrome P450 3A by paclitaxel in mice: pivotal role of the nuclear xenobiotic receptor, pregnane X receptor.

  2003cited by this paper
• Regulatory Gene Mutations Affecting Apolipoprotein Gene Expression: Functions and Regulatory Behavior of Known Genes May Guide Future Pharmacogenomic Approaches to Therapy

  2003cited by this paper
• The small heterodimer partner interacts with the pregnane X receptor and represses its transcriptional activity.

  2003cited by this paper
• The orphan nuclear receptor HNF4α determines PXR- and CAR-mediated xenobiotic induction of CYP3A4

  2003cited by this paper
• Peroxisome proliferator-activated receptor-gamma coactivator-1 gene locus: associations with obesity indices in middle-aged women.

  2002cited by this paper
• Induction of cytochrome P450 3A4 in primary human hepatocytes and activation of the human pregnane X receptor by tamoxifen and 4-hydroxytamoxifen.

  2002cited by this paper
• The effect of cyclophosphamide with and without dexamethasone on cytochrome P450 3A4 and 2B6 in human hepatocytes.

  2002cited by this paper
• A genetic variation in the PGC-1 gene could confer insulin resistance and susceptibility to Type II diabetes

  2002cited by this paper
• Cytochrome P450 regulation by hepatocyte nuclear factor 4 in human hepatocytes: A study using adenovirus‐mediated antisense targeting

  2001cited by this paper
• Corepressors and nuclear hormone receptor function.

  2001cited by this paper
• The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux

  2001cited by this paper
• Nuclear receptors and lipid physiology: opening the X-files.

  2001cited by this paper
• Alleles of the Estrogen Receptor α‐Gene and an Estrogen Receptor Cotranscriptional Activator Gene, Amplified in Breast Cancer‐1 (AIB1), Are Associated with Quantitative Calcaneal Ultrasound

  2000cited by this paper
• Mechanism of corepressor binding and release from nuclear hormone receptors.

  1999cited by this paper
• The use of human hepatocyte cultures to study the induction of cytochrome P-450.

  1999cited by this paper
• The CoRNR motif controls the recruitment of corepressors by nuclear hormone receptors

  1999cited by this paper
• Induction of cytochrome P4503A by taxol in primary cultures of human hepatocytes.

  1998cited by this paper

• The Glitazars Paradox: Cardiotoxicity of the Metabolically Beneficial Dual PPARα and PPARγ Activation.

  2020cites this paper
• The anticancer effects and mechanisms of fucoxanthin combined with other drugs

  2019cites this paper
• Mechanistic Insights of Phenobarbital-Mediated Activation of Human but Not Mouse Pregnane X Receptor

  2019cites this paper
• The regulation of human hepatic drug transporter expression by activation of xenobiotic-sensing nuclear receptors

  2016cites this paper
• Quantitative High-Throughput Identification of Drugs as Modulators of Human Constitutive Androstane Receptor

  2015cites this paper
• Role of pregnane X receptor in chemotherapeutic treatment

  2014cites this paper
• Extrahepatic metabolism at the body's internal–external interfaces

  2014cites this paper
• Spatial Profiling of Nuclear Receptor Transcription Patterns over the Course of Drosophila Development

  2013cites this paper
• PXR antagonists and implication in drug metabolism

  2013cites this paper
• Development of an adverse outcome pathway from drug-mediated bile salt export pump inhibition to cholestatic liver injury.

  2013cites this paper
• Fucoxanthin Attenuates Rifampin-Induced Cytochrome P450 3A4 (CYP3A4) and Multiple Drug Resistance 1 (MDR1) Gene Expression Through Pregnane X Receptor (PXR)-Mediated Pathways in Human Hepatoma HepG2 and Colon Adenocarcinoma LS174T Cells

  2012cites this paper
• Clinical Aspects of Drug Biotransformation: An OverviewDedicated to the memory of Mark J. Winn, Ph.D.,1960–1993

  2012cites this paper
• Role of nuclear receptor SHP in metabolism and cancer.

  2011cites this paper
• Regulation of drug-metabolizing enzymes by xenobiotic receptors: PXR and CAR.

  2010cites this paper
• An update on the pathobiological relevance of nuclear receptors for cancers of the head and neck.

  2010cites this paper
• Alterations of chemotherapeutic pharmacokinetic profiles by drug–drug interactions

  2009cites this paper
• Nuclear receptors in head and neck cancer: current knowledge and perspectives

  2009cites this paper
• Regulation of drug metabolism and transporters.

  2009cites this paper